Core Team - Aravis

Aravis is managed and advised by an international team of industrial and venture capital experts.

Omeros Announces $16.2 Million Registered Direct Offering of Common Stock

Biotie: Selincro launched in the United Kingdom

Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721

Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis

ARAVIS SA
Merkurstrasse 70, CH-8032 Zurich
Tel +41 43 499 2000
Fax +41 43 499 2001